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ABSTRACT 
Purpose: The present studies address the questions if visual dysfunction in severely 
visually impaired children can be measured with contrast tests high or low, how it 
relates to their visual abilities assessed with behavioural methods and if visual function 
in these children can be improved by neuro-pharmacological treatment.  
Methods: Twenty children aged 6-16 years from the Al-Maktoom school for visually 
impaired children in Islamabad, Pakistan were included in the first study and 22 
children aged 6-14 years in the second study. The children were divided into two 
different groups of visual impairment. One group with congenital cataract, late 
surgery and inadequate postoperative treatment, causing vision deprivation amblyopia 
(VDA), and the other group with mainly retinal and optic nerve disease causing 
peripheral visual impairment (PVI). The intension was to compare the results of 
visual assessment in the two groups as a basis for suitable interventions based on the 
type of visual dysfunction.Both high and low contrast visual acuity was assessed, 
using cardboard letter charts. Previous studies in children with visual handicap had 
shown that visual function assessment with these tests corresponded quite well with 
assessment of the functional ability of the children.In the second study, all children 
received an intramuscular injection of 1 g of citicoline for 10 consecutive days. Both 
high contrast and low contrast visual acuity was tested with methods described 
earlier. Acuity was measured at baseline (day 1), on day 30 and on day 90. Such 
studies have not been performed in children with severe visual impairment and 
treatment effects of citicoline have not been examined. 
 
Results: The distance high contrast tests were generally not well correlated among 
themselves in either group, whereas the near vision and low contrast tests were better 
correlated in the VDA group  than in the PVI group. The low contrast tests were well 
correlated amongst themselves in the VDA group. It was also noted that the group with 
VDA had better functional ability to cope with the tasks put to them.In the second study 
an improvement in visual acuity of children with VDA was seen mainly during the 
period up to 30 days after citicoline treatment, while the improvement in the children 
with PVI occurred during a longer period, up to 90 days. A decline in acuity after 
treatment was observed in 2/11 children with VDA and 3/11 children with PVI.  
 
Conclusion: For a broad evaluation of the visual capabilities of children with impaired 
vision it is suggested that the visual examination should include both high- and low-
contrast tests and functional vision assessment. The results of this pilot study on 
Citicoline effects are encouraging but extended examinations are needed to determine 
treatment procedures for citicoline treatment of visual dysfunction in children with 
severe visual impairment. 
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1 INTRODUCTION 
The present studies address the questions if visual dysfunction in severely visually 
impaired children can be measured with contrast tests high or low, how it relates to 
their visual abilities assessed with behavioural methods and if visual function in these 
children can be improved by neuro-pharmacological treatment.  
Tests for visual acuity at different contrast levels have been developed during recent 
years, but an evaluation of visual function with these tests in children with severe visual 
impairment has not previously been done, and the results from visual acuity testing 
have not been related to assessment of functional vision (Siddiqui et al., 2005). 
Treatment for most diseases causing visual impairment in children is quite limited. To 
the lesions of the structures of the eye and brain is often added the effects of abnormal 
development of the visual brain. Recently drugs supporting recovery in neurological 
disease have been introduced and they have been used also in ophthalmology, 
particularly in glaucoma and amblyopia, but their effects on lesions causing visually 
impairment in children have not been studied (Gottlob and Stangler-Zuschrott, 1990; 
Leguire et al., 1993; Parisi et al., (1999); Fresina et al., 2008; Rejdak at al., 2002; 
Campos et al., 1995; Porciatti et al., 1998). 
1.1  CAUSES OF VISUAL IMPAIRMENT IN CHILDREN 
In the present studies performed in Pakistan, children with severely reduced visual 
function have been included but not children with total loss of vision and blindness. 
The spectrum of diseases encountered is that of the developing countries: genetic 
diseases, malnutrition, infections, tumours and trauma. The lesions are affecting 
different parts of the eye and the visual pathways. Some conditions are inborn, others 
are inflicted in the foetal stage or at a very early age, and still others occur during the 
first years of life (Siddiqui et al., 1996). In developed countries visual loss associated 
with brain damage due to injuries at birth is the single greatest cause of visual 
impairment in children.  
1.2  DISEASES OF THE EYE AND BRAIN 
Disorders of the eye and the anterior visual pathways affect the quality of the visual 
image. The main diseases of the eye in visual impairment of childhood include 
opacities of the optical parts of the eye, e.g. corneal opacities and cataract, inborn 
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diseases of the retina and optic nerve, abnormal development of the retinal vascular 
system in retinopathy of prematurity (Gogate et al.,2011). 
Disorders of the posterior visual pathways including the primary visual cortex will 
affect visual processing and may also lead to visual field defects if the damage is 
unilateral, or to severely reduced vision if the lesions are bilateral. Disorders in the 
visual associative cortices are often patchy, affecting specific visual sub-functions, such 
as recognition of persons, perception of objects, size or directions, and of movement 
and speed of objects. The main causes of lesions in the posterior pathways are genetic 
disease or infections of the nervous system, and hypoxic ischemic insults both in full-
term and preterm infants. However, visual dysfunction due to lesions of the posterior 
visual pathways may be compensated by mechanisms involving ‘plasticity’ of the 
infant brain, an essential factor in the apparent visual ‘recovery’ that is described so 
frequently in these children. It is possible that such improvements in function could be 
supported by neuro-pharmacological treatment. 
As Dutton and co-workers have pointed out, children with hypoxic insults may have 
visual acuity and visual field loss coupled with specific visual disabilities attributed to 
damage to the dorsal stream system (parietal lobe) or ventral stream system (temporal 
lobe). Even more challenging are the children, who present with normal or slightly 
reduced acuities but with significant cognitive visual dysfunction (Dutton et al., 2006). 
The associative visual cortex areas contribute a significant portion of the visual 
disability in a number of children with brain damage and visual disability (Huo et al., 
1999).  
 
1.3  VISUAL DEPRIVATION - AMBLYOPIA 
If abnormalities of the eye occur early in life, and if the obstacles to vision are not 
removed at an early age, the normal development of the visual brain is impaired, 
leading to deprivation of visual function. The reduced visual function can be reversed if 
treatment is instituted during the so-called sensitive period of visual development, the 
main part of which is occurring during the first 3 – 4 years of life. The condition of 
visual dysfunction that remains after no or insufficient treatment against visual 
deprivation is termed amblyopia. It has been well established through animal studies 
that amblyopia is represented by functional and morphological modifications in the 
lateral geniculate nucleus and the visual cortex. When amblyopia exists, it can be cured 
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if adequately treated in children less than 6-7 years of age, but even in older patients 
some visual improvement can be achieved with therapy (Noorden and Campos, 2002). 
Combined with amblyopia is the phenomenon of crowding or separation difficulties, 
implying that small objects are easier to detect when they are presented in isolation than 
when they are included in a crowded surrounding. Crowding is observed also in other 
types of visual impairment, but is a more prominent feature in amblyopia (Noorden and 
Campos, 2002) 
In the present group of children with impaired vision, the main cause for amblyopia and 
visual deprivation was congenital or early cataract that had been operated too late, i.e. 
after the age of 3 months, in combination with no or deficient postoperative amblyopia 
treatment.  
1.4  PERIPHERAL VERSUS CENTRAL VISUAL IMPAIRMENT 
The children in the present studies had visual handicap either mainly due to retinal and 
optic nerve disease or to congenital cataract operated late and with less than optimal 
rehabilitation, leading to visual deprivation and functional changes in the posterior 
visual pathways.  
 
The children were subsequently divided into two different groups of visual impairment. 
One group with mainly retinal and optic nerve disease causing peripheral visual 
impairment (PVI) and the other group with congenital cataract, late surgery and 
inadequate postoperative treatment, causing vision deprivation amblyopia (VDA). The 
intension was to compare the results of visual assessment in the two groups as a basis 
for suitable interventions based on the type of visual dysfunction (Siddiqui et al., 2005) 
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2  TREATMENT METHODS 
 
2.1  IN DISEASES OF EYE AND BRAIN  
For eye diseases caused by infections and malnutrition effective treatment is available, 
although not sufficiently applied in developing countries due to limited resources of 
medical care. For inherited disorders of the eye and brain very limited medical 
treatment is available. Opacities of the optical media, as a result of corneal disease and 
cataract, can be removed by surgery (Siddiqui et al., 1996). Retinopathy of prematurity 
can be treated by different kinds of retinal surgery. Hypoxic brain insults may be 
prevented or reduced by adequate neonatal care. In rehabilitation for visual impairment 
different methods are used such as adaptation of light and colour of the environment to 
suit the kind of visual impairment, educational methods to use remaining visual 
function appropriately through compensating mechanisms. 
 
Visual rehabilitation does not need to be extremely intricate and expensive strategies 
involving assistive devices. 
 
The use of strategies as the Little room, utilizing the “Active Learning “ technique  
maintain that children who are blind with additional disabilities learn best by being 
actively involved in their environment without direct adult intervention. Lilli Nielsen 
encouraged educators and families to design the environment in such a way that 
children are motivated to reach out and explore their surroundings (Newton, 2012). 
Good optometric and ophthalmic services are now helping most of the school going 
children whether in segregated (Special schools) or inclusive education in Pakistan      
(Siddiqui et al., 1996). 
 
2.2  IN VISUAL DEPRIVATION- AMBLYOPIA  
The treatment is directed towards reducing causes of vision deprivation by surgery at 
an early age for corneal opacity, cataract or any other condition, affecting the ocular 
media, followed by correction of refractive errors, including anisometropia. In 
conditions where one eye is better equipped than the other in terms of visual image 
quality, and suppression of the poorer eye is expected, different methods of stimulating 
vision of the poorer eye is instituted. The most efficient way of such amblyopia 
treatment is by occlusion of the better eye with a patch for different periods of time, 
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depending on the severity of amblyopia, but methods of pharmacological treatment has 
also been used (Noorden and Campos, 2002). 
 
2.3 PHARMACOLOGICAL TREATMENT  
Topical treatment with mydriatics is mainly done in amblyopia caused by strabismus 
and anisometropia. Blurring of the good eye with atropine as an amblyopia treatment 
has recently been shown to be as effective as conventional occlusion therapy 
(Li and Shotton, 2009), Menon et al., 2008). 
 
The effect of centrally acting neurotransmitters especially Levodopa on vision in 
amblyopia has been studied by Gottloeb and Stangler-Zuschrott (1990) and Leguire at 
al. (1993) and the results were   encouraging. However, the improvement of visual 
acuity declined after one month of medication (Gottloeb and Stangler-Zuschrott 1990; 
Leguire et al., 1993). 
The side effects noted were few and mostly dose dependant. 
The commonest side effects were nausea, tiredness, headache, earache and sore throat 
(Leguire et al., 1993). 
 
Systemic treatment with citicoline has been used to improve vision in different types of 
eye diseases including amblyopia. Citicoline was first introduced in treatment of 
neurological disease such as stroke and traumatic brain injuries and it was found to 
improve the functional outcome and reduce neurological deficit. Citicoline is an 
intermediate metabolite in the major pathway for the synthesis of the membrane 
phospholipids and can support neuronal cell-membrane function that has been damaged 
by trauma, ischemic events, toxins, infections or neural degeneration (Parisi et al., 
1999; Rejdak et al., 2002; Campos et al., 1995). 
 
Patients in the studies of neurological impairment have reported that colors were 
brighter and that visual contrast was enhanced, which have led to investigations of 
citicoline effects in various ophthalmic conditions. Studies in patients with glaucoma 
have suggested that citicoline repairs damage to the optic nerve and the retina.  
 
Citicoline was found to significantly improve visual acuity and contrast sensitivity in 
patients with amblyopia, mainly in the amblyopic eye, and some increase in contrast 
vision was reported also in the better eye (Porciatti et al., 1998). The long term effect 
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improvement lasted till 6 months and no side effects were reported and a suggested 
regime has been to prescribe treatment twice a year (Campos and Fresina, 2006). 
 
Oral citicoline has been tried in amblyopic children in conjunction with occlusion and 
the results showed that although citicoline with patching was not more effective than 
patching alone, it seemed to stabilize the results for longer (Fresina et al., 2008). 
 
 In view of the findings of citicoline effects on retinal and optic nerve function in 
glaucoma and visual cortical function in amblyopia, we have examined the effects of 
citicoline on visual acuity and contrast vision in children with severe visual handicap.  
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3 VISUAL FUNCTIONS AND TESTING 
 
3.1  VISUAL ACUITY 
Visual acuity is a measure of the spatial resolution of the visual processing system and 
is usually tested with black objects and symbols on a white background for maximum 
contrast. Visual acuity is specified in terms of the visual angle subtended by finest 
spatial detail detected.  
There are generally considered to be three types of visual acuity measures: detection 
acuity, resolution acuity, and identification/recognition acuity. 
Detection acuity implies that the stimulus should be detected or distinguished from the 
background. In young children this function can be assessed with the Stycar rolling 
balls. In measuring the visual acuity the size of the object and the distance should be 
used. 
In resolution acuity, the stimulus pattern is usually a black and white grating and this 
function can be tested by various preferential looking tests which is based on the fact 
that the child will look at the pattern. Grating acuity is reported in cycles/degree. 
In recognition acuity the stimulus, a letter, symbol or number, should be recognized by 
the subject and /or identified by matching or naming. In visual acuity testing the 
minimal angle of resolution is estimated in minutes of an arc (Rydberg, 1998). 
There are many types of visual acuity charts. The first was presented in 1862 by 
Hermann Snellen. He defined “standard vision” as the ability to recognize an optotype, 
a letter, with a bar width of 1 minute of arc. The optotypes in most visual acuity charts 
have the overall size that is five times that of the width of the optotype bar (Sloan, 
1951). 
 
Subsequently many different visual acuity charts have been designed, all based on the 
same principle, with letters or other symbols. The visual acuity measure is the minimal 
angle of resolution in relation to normal acuity. It can be expressed in decimals or 
fractions of normal acuity.  
Louise Sloan (1959) presented a new optotype set of 10 letters, all to be shown in each 
line tested, in order to avoid the problem that not all letters are equally recognizable. 
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The larger letter sizes thus required more than one physical line. The Sloan test is 
presented at a distance of 20 feet or 6 m (Sloan, 1959). 
 
Lea Hyvärinen created a chart, using figures (an apple, a house, a circle and a square) 
and arabic numbers (0 – 9) to measure visual acuity in preschool children. If the child 
could not name the optotype, he/she could indicate it by pointing to it on a matching 
chart with the symbols in front of him/her.  The Lea tests are designed for testing at a 
distance (3 m) or near (40 cm) (Hyvärinen, 1998). 
 
3.2  CONTRAST SENSITIVITY 
Contrast is defined as the luminosity difference between object and surround. It is 
expressed in percent of the luminosity of the surround. Contrast sensitivity defines the 
lowest contrast level at which an object can be detected for a given size target. 
Normally a range of various target sizes are used in testing contrast sensitivity. 
Therefore contrast sensitivity measurements include two variables, size and contrast, 
while acuity measures represent size at a fixed contrast. Contrast sensitivity is measured 
clinically either with a set of charts consisting of bars with sinusoidal luminosity profile 
at varying bar width and contrast levels, or charts consisting of optotypes of varying 
size with square wave luminosity profile and varying contrast. Contrast sensitivity is 
expressed as a function of sensitivity against pattern size (Regan and Neima1983). 
 
Among the tests available, the Vistech chart uses grating patterns, whereas most other 
charts e.g. Pelli-Robson and LH use optotype sets (Hyvärinen et al., 1990, Regan and 
Neima, 1983, Ferris et al., 1982). 
 
Contrast sensitivity testing has proved useful in early diagnosis of retinal disorders, 
including diabetic retinopathy, age-related macular degeneration, and a variety of other 
retinal disorders. Additionally, measurement of the contrast sensitivity function has also 
been reported to be effective in revealing subtle visual losses in optic neuritis and 
multiple sclerosis, other optic neuropathies and amblyopia, 
 
In addition to providing useful information about the functional integrity of the visual 
pathways, there is also evidence that the contrast sensitivity testing of low vision 
patients may be helpful in predicting the performance of various "real world" tasks, 
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such as recognition of obstacles in dim light, reading ability, face recognition, and 
orientation and mobility skills (Hyvärinen and Jacob, 2011). 
 
3.3 FUNCTIONAL VISION 
Interest in and need for functional correlates of visual measurement were first 
stimulated at the national level by development of the legal concept of indemnification, 
or liability, in Germany and Great Britain in the late 19th century. This development 
was spurred by industrialization and its resulting disabling accidents. The concept was 
brought to focus by Hugo Magnus, a one-time professor of ophthalmology in Germany, 
in a book on "visual economics" first published in German in 1894, and translated, with 
revisions, into English in 1902 (Ryan, 1962). 
 
The full early history of attempts to quantify the functional implications of visual 
impairment, typically again for disability compensation purposes, is well reviewed 
elsewhere (Ryan, 1962). Various functional assessment testing algorithms are available 
with Jill Keefe’s book for assessment in developing countries approved by the WHO 
and the VFQ 25 supported by the National Eye Institute (Keefe ,1995); NEI-VFQ-
2000). 
  
More recently Lea Hyvärinen presented a simple method of assessing the functional 
level of vision in school children. Functional vision was evaluated in five areas: 
communication, orientation, mobility, activities of daily life, sustained near vision 
tasks. This method was found to be easy to learn and repeat. The assessment of 
functional vision has not previously been compared with visual acuity and contrast 
sensitivity in a group of visually impaired children (Siddiqui et al., 2005). 
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4 AIMS AND  OBJECTIVES OF THE STUDY 
 
The aims have been to study in children with visual impairment 
- correlation between the results of high contrast and low contrast visual acuity 
tests   in low vision children 
- correlation between the contrast tests and functional visual assessment in low 
vision children 
- differences in such testing with regard to peripheral and central visual 
dysfunction in low vision children 
- effects of Citicoline treatment on contrast vision, also with regard to peripheral 
and central visual impairment in low vision children 
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5  MATERIALS AND METHODS: 
 
5.1  PAPER I  
Twenty children aged 6-16 years from the Al-Maktoom school for visually impaired 
children in Islamabad, Pakistan were included. Eleven of the children were girls and 9 
boys.  
The children were examined clinically for visual acuity, ocular motility status, 
anterior segment bio microscopy, fundus examination and refraction.  
 
The children were divided into two groups: 
 
1. The visual dysfunction was regarded as central (vision deprivation amblyopia, 
VDA). 
 
Nine children had been operated late for congenital cataract and suffered vision 
deprivation. 
 
2. The visual dysfunction was regarded as mainly peripheral (peripheral visual 
impairment, PVI). 
 
Eleven children had retinal or optic nerve related diagnoses such as albinism, rod/cone 
dystrophy, retinal degeneration and primary optic atrophy. All children except three in 
the group with peripheral visual impairment showed nystagmus of the sensory type as a 
result of the early onset of severe visual impairment. 
 
Both high and low contrast visual acuity was assessed, using cardboard letter charts. 
Previous studies in children with visual handicap had shown that visual function 
assessment with these tests corresponded quite well with assessment of the functional 
ability of the children (Siddiqui et al., 2005).  
 
The distance visual acuity was assessed with the following high contrast distance tests 
at 90% contrast: Lea Symbol High Contrast test (Lshc), Lea Number High Contrast test 
(Lnhc) and Sloan Letter High Contrast tests (Slhc).  
 
12 
 
The distance low contrast tests presented at a contrast of 2.5 % were: Lea Symbol Low 
Contrast (Lslc), Lea Number Low Contrast (Lnlc) and Sloan Letter Low Contrast test 
(Sllc).  
The near vision was tested with the near vision Lea Hyvärinen test (Nvlh) for a distance 
of 40 cm. 
 
The visual acuity was recorded as the last line on which at least 3 out of 5 symbols 
were identified correctly except when the line was read twice, in that case 4 out of 5 
were acceptable (Precision Vision TM, testing instructions). Visual acuity was 
recorded using the decimal notation. If not even the largest optotypes were identified, 
this was marked as “no response” and given an arbitrary acuity value of 0.01 in the 
statistical analysis.  
 
Functional vision was evaluated in five areas: 
 
Communication (use of facial expressions, visual initiation of communication).  
Orientation (awareness of the surroundings at different levels of light). 
Mobility (control of posture and body movements and ability to move in the 
environment) 
Activities of daily life (participation in activities at school and home, performance in 
games). 
Sustained Near vision tasks (performance with pictures and text, fixation pattern, need 
for optical devices).  
 
The performance in the tasks were graded by the low vision teachers from 1 to 5 
wherein 
 1= blind behaviour and 5= sighted behaviour. For each child a total score of all test 
areas was calculated. 
 
The Student´s t-test was used to compare visual acuity values between the two groups. 
Pearson´s correlation coefficient was used to compare high-contrast acuity, low-
contrast acuity and functional vision scores. 
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5.2  PAPER II  
A second group consisted of twenty-two children, age range 6 -14 years, with severe 
visual impairment, students the Al Maktoom School for the Visually Impaired. None of 
the children participated in the previous study of Paper I. 
 
One group of 11 children had been operated late for congenital cataract, resulting in 
vision deprivation amblyopia (VDA). 
Another group of 11 children presented with retinal or optic nerve disease and 
peripheral visual impairment (PVI).  
All children received an intramuscular injection of 1 g of citicoline for 10 consecutive 
days.  
Both high contrast and low contrast visual acuity was tested with methods described 
earlier. Acuity was measured at baseline (day 1), on day 30 and on day 90. Such studies 
have not been performed in children with severe visual impairment and treatment 
effects of citicoline have not been examined. 
 
The visual acuity effects were also evaluated as the change from the baseline 
examination in the number of lines identified on the acuity chart. An improvement or a 
decline of two to three lines was considered a moderate effect, and a change of four 
lines or more as a marked effect.  
 
The subjective changes of visual function were evaluated with the following questions 
put to the child at the examination on day 30 and 90: 
Do you notice any brightening or darkening of light around you? 
Do you think that the colours around you appear brighter/clearer or darker? 
 
On the visual acuity data an ANOVA for repeated measures analysis was performed. 
The data were further examined for trends with a linear contrast analysis. All analyses 
were done with the STATISTICA, version 7. 
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6 RESULTS 
 
6.1 PAPER I 
The results of the examination of visual function for the different optotypes and 
contrast tests are shown in Table 1A for the group with visual deprivation amblyopia 
(VDA) and Table 1B for the group with peripheral visual impairment (PVI). The mean 
values and standard deviations are presented. The values are expressed as Snellen 
visual acuity in the decimal notation with Log MAR in parenthesis.  
 
Table 1A. Results of testing of near and distance contrast vision in nine children with 
Vision deprivation amblyopia (VDA). Mean values and standard deviation in Snellens decimal. 
Tests 
Contrast 
Nvlh 
high 
Lshc 
high 
Lnhc 
high 
Slhc 
high 
Lslc 
low 
Lnlc 
low 
Sllc 
low 
Mean 0.12 0.16 0.134 0.133 0.059 0.051 0.043 
Std Dev 0.09 0.074 0.087 0.056 0.037 0.035 0.035 
 
Table 1B. Results of testing of near and distance contrast vision in eleven children with 
Peripheral visual impairment (PVI). Mean values and standard deviation in Snellens decimal. 
Tests 
Contrast 
Nvlh 
high 
Lshc 
high 
Lnhc 
high 
Slhc  
high 
Lslc  
low 
Lnlc 
low  
Sllc  
low 
Mean 0.065 0.101 0.081 0.076 0.044 0.036 0.032 
Std Dev 0.040 0.041 0.040 0.034 0.034 0.033 0.023 
A reduction of the contrast resulted in a decrease in visual acuity in the visually 
impaired children of both groups. The acuities in children with VDA were higher than 
in those with PVI and a significant difference between the two groups was found for 
Lshc and Slhc. 
Comparison of different contrast tests showed that high contrast tests were not 
correlated amongst themselves or to low contrast tests. In contrast low contrast tests 
showed good correlation amongst themselves and seem to be more reliable for contrast 
vision assessments of visually impaired children. Looking at the correlation of all tests 
irrespective of the group reveals the results as if they were an admixture of correlations 
of both groups. Nvlh was significantly correlated with two low contrast tests; Lshc was 
significantly correlated with all the tests except Lslc; Lnhc was only correlated with 
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Slhc; and low contrast tests were all very well correlated amongst themselves, whereas 
the near vision and low contrast tests were better correlated in the VDA group than in 
the PVI group.The low contrast tests were well correlated amongst themselves in the 
VDA group. 
 
The mean score of the functional assessment is shown in table 2A for visual deprivation 
amblyopia (VDA) and in table 2 B for peripheral visual impairment (PVI). The value 
for the central impairment group was nearly equal to the normally sighted with a mean 
of 23.44 in the total score. In the peripheral group, however scores were reduced for all 
the fields of assessment with a mean of 18.47.  
 
Table 2A. Scores for functional assessment in eleven children with vision deprivation 
amblyopia (VDA). Mean values. 
 Communication Orient Mob ADL Snvt Total 
Mean 4.66 4.77 4.88 4.88 4.22 23.44 
 
Table 2B. Scores for functional assessment in nine children with peripheral visual 
impairment (PVI). Mean values.  
 Communication Orient Mob ADL Snvt Total 
Mean 3.81 3.91 3.63 3.91 2.55 18.27 
 
In children with peripheral visual impairment correlations existed with most of the low 
contrast tests and all the functional abilities except mobility. Due to little or no variation 
in the functional assessment of children in the central group, assessment of correlations 
to contrast test values could not be performed.  
 
6.2  PAPER II 
All children but two, both in the group with peripheral visual impairment reported 
subjective increase in brightness and colour during and up to 30 days after the citicoline 
treatment.  
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The baseline values of visual acuity at high- and low-contrast levels were not 
statistically different between the two groups. The over-all effect of citicoline treatment 
was an increase in visual acuity over time in both groups, but the change from baseline 
was not statistically significant.  At 30 days after treatment start visual acuity had 
increased in the group with central impairment and it remained at this value in some 
children but decreased in others at the 60 days and 90 days test. In the group with 
peripheral impairment the effects were more varied, but an increase in low-contrast 
values were more common than in high-contrast testing.  The statistical analysis 
showed a close to significant increase in visual acuity in the group with peripheral 
impairment but not in the group with central impairment. 
Figure 1. Mean values in visual acuity for the HCA and for LCA  
The clinical assessment of visual acuity change, evaluated as the change in the number 
of lines seen on the chart, showed a moderate and marked improvement of high-
contrast vision in 6/11 children with central visual impairment and in 3/11 children 
with peripheral visual impairment. Low-contrast vision was improved in 3/11 children 
with central impairment but only in one child with peripheral impairment. The 
improvement in children with central visual deprivation was seen mainly during the 
period up to 30 days after citicoline treatment, while the improvement in the children 
with peripheral visual impairment occurred during a longer period, up to 90 days. A 
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decline in acuity after treatment was observed in 2/11 children with VDA and 3/11 
children with PVI.  
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7  DISCUSSION 
 
7.1  GROUPING OF THE STUDY POPULATION 
At the very outset of testing it was noticed that the children had two distinct aetiological 
diagnoses. (Siddiqui et al., 2005). It appeared logical at that stage to group them 
accordingly. 
 
We grouped the children with history of delayed surgery for congenital cataracts, 
corneal opacities and other media opacities into “Vision Deprivation Amblyopia” 
(VDA). The commonality being the hindrance to visual stimulation due to anterior 
segment related causation. 
 
In children with infantile cataracts, the timing of the surgery and its relation to the 
duration of deprivation, accurate optical rehabilitation and post-operative supervision 
are essential. Cataract surgery amongst infants should generally be done within 6-10 
weeks of birth (Lloyd et al 2007), and surgery delayed beyond this very short period 
would lead to visual acuity not improving beyond 6/60 or 1.0 (LogMAR) [0.1 in 
decimal Snellen and 20/200 when converting to feet] even after the most aggressive 
optical rehabilitation (Ruth and Lambert, 2006). 
 
In most of our children the surgery was not done till they were 8 years or above, 
therefore the chance of any optical correction leading to improvement of vision was far 
gone. For some of them the surgery was done within a few years of birth the optical 
rehabilitation was not optimal.  
 
The children whose basic cause of visual impairment were from causes related to 
affecting the first order neurons and beyond i.e, optic atrophy, macular hypoplasia and  
other  retino-optic causes were grouped into the “Peripheral Visual Impairment 
group”(PVI) (Siddiqui et al, 2005).  
 
7.2  VISION TESTING METHODS 
All the children were tested with the same tests in high and low contrast card board 
based tests using various symbols, (Siddiqui et al., 2005). In clinical settings only a few 
tests are available to assess low contrast acuity in children (Rydberg et al., 1997). 
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Low contrast tests based on gratings are usually thought of being time consuming and 
more difficult to understand for most subjects especially children and, therefore, we 
have used card board based tests which have the same symbols as the high contrast 
tests so that it would be more convenient for children to respond also bearing in mind 
these children were all visually impaired. Visual information at low contrast levels is 
important in communication and orientation and mobility but also in seeing black-and-
white photographs and pastel colour paintings and pictures. Contrast sensitivity is 
decreased in many diseases. Corneal opacities, cataract, optic nerve atrophy and retinal 
degenerations are the most common (Hyvärinen, 1997) 
In the 1980’s Regan and Neima, Pelli and Robson,  Hyvärinen, and various 
practitioners came up with their versions of chart based Low contrast tests which 
brought the testing of low contrast from the laboratory into the clinic (Pelli et al., 1988, 
Hyvärinen et al., 1990, Regan and Neima, 1983) 
 
In particular, the charts picked up visual loss that was not detected by the standard 
Snellen chart: they detected visual pathway dysfunction in all seven patients whose 
sinewave data were abnormal (Regan and Neima, 1983) 
 
On average, a four-line (0.4 logMAR) reduction in acuity should be expected when one 
is comparing high-contrast acuity with a 2.5% low-contrast acuity measurement using 
Lea symbols (Little et al.,2013). 
 
This is further confirmed by Lea Hyvärinen who states that in groups of visually 
normal children, the mean value of low contrast visual acuity values is slightly less than 
half of the full contrast visual acuity value (Lea test webpage). 
 
In this study the low contrast acuities were  less than half of the high contrast acuities  
for all of the test charts used (Table 1 A and B).  
 
The visual acuity was generally higher both for high- and low-contrast testing in the 
children with visual deprivation than in the children with retinal and optic nerve disease 
(Paper I).  
 
As pointed out by Lewis and Maurer, patterned visual input immediately after birth 
plays a vital role in the construction and preservation of the neural architecture that later 
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on mediates higher and lower aspects of vision. Both systems of development of fine 
acuity and low contrast acuity are refined by later visual experience which is present in 
children with congenital cataracts whereas the children with retino-optic and macular 
lesions would not have the possibility of such stimuli (Lewis and Maurer, 2009). 
 
It was seen that the High contrast tests did not correlate well among themselves or to 
low contrast tests, whereas the low contrast tests correlated well among themselves and 
seem to be more reliable for contrast assessments of visually impaired children. 
 
7.3  FUNCTIONAL ASSESSMENT 
Functional assessment seems to be a more holistic way of assessing children so that 
their needs can be looked in more detail. It also helps us in making a more well-
rounded picture of the child. It was encouraging to note that the children mostly were 
well adjusted in spite of their impairment. (Paper 1) 
 
Jill Keefe designed a detailed functional assessment booklet to be used in the 
developing countries and is approved by the WHO (Keefe 1995). It was found to be 
rather detailed and time consuming and required quite a bit of training for the teachers.  
 
The National Eye Institute VFQ-25 is another well accepted but very detailed method 
used to quantify Functional vision (NEI-VFQ,2000).  
 
The Functional assessment protocol used in our studies was the simplest and most 
easily taught method and it has been tried and tested in children in a different countries 
of the world (Hyvärinen, 1998).  
 
We used four different tasks to be assessed i.e. Communication, orientation and 
mobility, activities of daily living and sustained near vision tasks and then graded them 
from 1-5 (Hyvärinen, 1998). 
Functional vision was almost normal for children with visual deprivation but not in the 
children with retinal or optic nerve involvement. The results of functional assessment 
were well correlated with low-contrast visual acuity in the children with retinal/optic 
nerve disease, therefore better at assessing communication and orientation and mobility 
tasks but lacking in assessing activities of daily living and sustained near vision tasks, 
i.e. reading. Increase in contrast in the later tasks would be beneficial for the children. 
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For a broad evaluation of the visual capabilities of children with impaired vision it is 
suggested that the visual examination should include both high- and low-contrast tests 
and functional vision assessment (Siddiqui et al., 2005).  
 
7.4  PHARMACOLOGICAL TREATMENT 
Over the last few years studies have been carried out to look into pharmacological 
treatment of amblyopia by medicines which were previously being used for different 
conditions for example levodopa and citicoline (Gottlob and Stangler-Zuschrott, 1990; 
Leguire et al., 1993; Campos et al., 1995; Porciatti et al., 1998). 
 
We have broadened the scope of citicoline use to included children with visual 
impairment due to visual deprivation  or to retino-optic causes. An increase in visual 
acuity, measured with high and low contrast tests were observed in both groups but the 
effect was not statistically significant. The change in visual acuity, based upon 
grouping on the basis of aetiological diagnoses have shown different results in both 
groups. The children in the VDA group, showed an improvement in the first 30 days of 
treatment whereas, the children in the PVI group showed more improvement between 
day 30 and 90. A more qualitative assessment of visual acuity, measured as the number 
of lines of improvement or decline on the acuity chart, also showed that citicoline 
improved vision, more in the children with visual deprivation than in children with 
retinal/optic nerve involvement.  
 
Most of the change did regress to baseline at the end of 4 months, which corresponds to 
the effects reported in patients with amblyopia (Parisi et a., 1999, Fresina et al., 2008, 
Campos et al., 1995; 1997). 
 
Citicoline seems to be safe when taken up to 90 days, and long term side effects are 
rare i.e., insomnia, headache, nausea, diarrhoea, blurred vision and low or high blood 
pressure. 
(http://www.webmd.com/vitamins-supplements/ingredientmono-1090-
CITICOLINE.aspx) 
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The results of this pilot study on citicoline effects are encouraging but extended 
examinations are needed to determine treatment procedures for citicoline treatment of 
visual dysfunction in children with severe visual impairment.  
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